Litcius/Paper detail

Inhibition of tiRNA-Gly-GCC ameliorates neointimal formation via CBX3-mediated VSMCs phenotypic switching

Zhihua Rong, Fengshi Li, Rui Zhang, Shuai Niu, Xiao Di, Leng Ni, Changwei Liu

2023Frontiers in Cardiovascular Medicine14 citationsDOIOpen Access PDF

Abstract

Background and aim tRNA-derived fragments (tRFs) are a new class of non-coding RNAs involved in a variety of pathological processes, but their biological functions and mechanisms in human aortic smooth muscle cells (HASMCs) phenotype transition and vascular intimal hyperplasia are unclear. Methods/results tiRNA-Gly-GCC is upregulated in synthetic HASMCs, atherosclerotic arteries, plasma, and the balloon injured carotid artery of rats. Functionally, the inhibition of tiRNA-Gly-GCC represses HASMCs proliferation, migration, and reversed dedifferentiation, whereas the overexpression of tiRNA- Gly-GCC have contrary effects. Mechanistically, tiRNA-Gly-GCC performs these functions on HASMCs via downregulating chromobox protein homolog 3 (CBX3). Finally, the inhibition of tiRNA-Gly-GCC could ameliorate neointimal formation after vascular injury in vivo . Conclusions tiRNA-Gly-GCC is a mediator of HASMCs phenotypic switching by targeting CBX3 and inhibition of tiRNA-Gly-GCC suppresses neointimal formation.

Topics & Concepts

Vascular smooth muscleDownregulation and upregulationNeointimal hyperplasiaNeointimaPhenotypeCancer researchChemistryCell biologyMediatorInternal medicineEndocrinologyBiologyMedicineBiochemistryRestenosisSmooth muscleStentGeneRNA modifications and cancerCancer-related molecular mechanisms researchRNA and protein synthesis mechanisms